Stocktoria
Lonza Group AG LONN.SW
Lonza Group AG (LONN.SW) earns a Piotroski F-score of 6/9 (mixed financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 0.74% (safety: safe). FY2025 revenue was $6.5B at a -4.2% net margin.
Price from month-end closes (Yahoo) — for reference, not real-time.
How it ranks in Healthcare · percentile among 23 companies
Percentile vs other Healthcare companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 6/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.179 |
| Retained earnings / assets | 0.385 |
| EBIT / assets | 0.076 |
| Equity / liabilities | 0.796 |
FAQ
Is LONN.SW financially healthy?
Lonza Group AG's Piotroski F-score is 6/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does LONN.SW pay a dividend, and is it safe?
Yes. Lonza Group AG pays a dividend yielding about 0.74% with a -102.5% payout ratio, rated “safe” for safety.
How profitable is LONN.SW?
In FY2025, Lonza Group AG had a net margin of -4.2% and a return on equity of -3.5%.
Source: company filings via Yahoo Finance · CH · as of 2025-12-31. Figures in CHF; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.